|
Name |
Bacillaene B
|
Molecular Formula | C40H58N2O11 | |
IUPAC Name* |
(3E,5E,7Z)-8-[[(4Z,6Z,8E,10E,12Z,14E)-3-hydroxy-4,9-dimethyl-16-[[4-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoyl]amino]hexadeca-4,6,8,10,12,14-hexaenoyl]amino]-2-methylnona-3,5,7-trienoic acid
|
|
SMILES |
CC(C)CC(C(=O)NC/C=C/C=C\C=C\C(=C\C=C/C=C(/C)\C(CC(=O)N/C(=C\C=C\C=C\C(C)C(=O)O)/C)O)\C)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O
|
|
InChI |
InChI=1S/C40H58N2O11/c1-26(2)23-32(52-40-37(48)36(47)35(46)33(25-43)53-40)38(49)41-22-16-9-7-8-11-17-27(3)18-14-15-19-28(4)31(44)24-34(45)42-30(6)21-13-10-12-20-29(5)39(50)51/h7-21,26,29,31-33,35-37,40,43-44,46-48H,22-25H2,1-6H3,(H,41,49)(H,42,45)(H,50,51)/b8-7-,13-10+,15-14-,16-9+,17-11+,20-12+,27-18+,28-19-,30-21-/t29?,31?,32?,33-,35-,36+,37-,40-/m1/s1
|
|
InChIKey |
QJHRJCZWJZGLQY-ILRPWICXSA-N
|
|
Synonyms |
Bacillaene B; CHEMBL4584991; J3.509.663I
|
|
CAS | NA | |
PubChem CID | 132602453 | |
ChEMBL ID | CHEMBL4584991 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 742.9 | ALogp: | 4.4 |
HBD: | 8 | HBA: | 11 |
Rotatable Bonds: | 21 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 215.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 53 | QED Weighted: | 0.079 |
Caco-2 Permeability: | -5.688 | MDCK Permeability: | 0.00000396 |
Pgp-inhibitor: | 0.012 | Pgp-substrate: | 0.961 |
Human Intestinal Absorption (HIA): | 0.89 | 20% Bioavailability (F20%): | 0.014 |
30% Bioavailability (F30%): | 0.994 |
Blood-Brain-Barrier Penetration (BBB): | 0.043 | Plasma Protein Binding (PPB): | 97.26% |
Volume Distribution (VD): | 0.331 | Fu: | 6.02% |
CYP1A2-inhibitor: | 0.033 | CYP1A2-substrate: | 0.024 |
CYP2C19-inhibitor: | 0.033 | CYP2C19-substrate: | 0.067 |
CYP2C9-inhibitor: | 0.005 | CYP2C9-substrate: | 0.183 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.091 |
CYP3A4-inhibitor: | 0.042 | CYP3A4-substrate: | 0.079 |
Clearance (CL): | 1.592 | Half-life (T1/2): | 0.901 |
hERG Blockers: | 0.431 | Human Hepatotoxicity (H-HT): | 0.985 |
Drug-inuced Liver Injury (DILI): | 0.795 | AMES Toxicity: | 0.031 |
Rat Oral Acute Toxicity: | 0.262 | Maximum Recommended Daily Dose: | 0.984 |
Skin Sensitization: | 0.929 | Carcinogencity: | 0.11 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
Respiratory Toxicity: | 0.921 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002839 | 0.382 | D0D0SH | 0.277 | ||||
ENC004780 | 0.382 | D0AT8C | 0.253 | ||||
ENC002883 | 0.382 | D0FG6M | 0.218 | ||||
ENC002660 | 0.296 | D02VCJ | 0.207 | ||||
ENC003819 | 0.288 | D02HYK | 0.203 | ||||
ENC004855 | 0.286 | D07BSE | 0.202 | ||||
ENC003820 | 0.274 | D0Y3MO | 0.201 | ||||
ENC004854 | 0.268 | D03JSJ | 0.200 | ||||
ENC003750 | 0.252 | D0Q2QU | 0.193 | ||||
ENC002949 | 0.241 | D0MY8N | 0.192 |